Bank of America’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7
Closed -$48 6564
2025
Q4
$48 Buy
7
+3
+75% +$34 ﹤0.01% 6967
2025
Q3
$56 Sell
4
-1
-20% -$15 ﹤0.01% 7982
2025
Q2
$95 Buy
5
+2
+67% +$40 ﹤0.01% 7973
2025
Q1
$67 Sell
3
-9
-75% -$187 ﹤0.01% 7911
2024
Q4
$218 Sell
12
-7
-37% -$207 ﹤0.01% 7570
2024
Q3
$687 Buy
19
+16
+533% +$491 ﹤0.01% 7316
2024
Q2
$65 Buy
+3
New +$150 ﹤0.01% 7793
2024
Q1
Sell
-1
Closed -$76 7513
2023
Q4
$61 Buy
+1
New +$118 ﹤0.01% 7467
2023
Q3
Hold
0
7549
2023
Q2
Hold
0
7476
2023
Q1
Hold
0
7535
2022
Q4
Hold
0
7677
2022
Q3
Hold
0
8094
2022
Q2
Sell
-160
Closed -$77.3K 8279
2022
Q1
$96K Sell
160
-56
-26% -$41.6K ﹤0.01% 6888
2021
Q4
$239K Buy
216
+130
+151% +$283K ﹤0.01% 6398
2021
Q3
$331K Buy
86
+24
+39% +$75.7K ﹤0.01% 5944
2021
Q2
$179K Sell
62
-117
-65% -$276K ﹤0.01% 6164
2021
Q1
$357K Buy
179
+176
+5,867% +$265K ﹤0.01% 5639
2020
Q4
$3K Sell
3
-192
-98% -$164K ﹤0.01% 6898
2020
Q3
$156K Buy
195
+169
+650% +$150K ﹤0.01% 5441
2020
Q2
$24K Buy
+26
New +$26K ﹤0.01% 6222
2020
Q1
Hold
0
7138
2019
Q4
Sell
-15
Closed -$6K 7312
2019
Q3
$6K Buy
+15
New +$6.85K ﹤0.01% 6811
2018
Q4
Sell
-1
Closed -$1K 7303
2018
Q3
$1K Buy
+1
New +$610 ﹤0.01% 7135
2017
Q2
Hold
0
-$1K 7108
2017
Q1
Hold
0
6864

Other funds holding PAVM

Bank of America's PAVM Position: Q1 2026 in Review

Bank of America sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 7 shares — an estimated $48 sold.

Bank of America first reported a position in PAVM in Q3 2018 and held it in 18 quarters. The position peaked at $357K in Q1 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Bank of America reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 7 PAVmed shares in Q1 2026, an estimated $48.
  • Bank of America first reported a position in PAVmed in Q3 2018 and held it in 18 quarters.
  • Bank of America's PAVmed position peaked at $357K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.